prev next front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |32 |review
Cell adhesion molecules (CAMs) mediate the adhesion of monocytes to the vascular endothelium, an initial step in atherogenesis. In 27 patients with hypertriglyceridemia and low HDL-C, treatment with purified n-3 fatty acid (Omacor) 4 g/d for at least 7 months not only reduced triglyceride by 47% and total cholesterol by 21%, but also reduced levels of soluble intercellular adhesion molecule 1 (sICAM-1) by 9% (p=0.02) and soluble E-selectin (sE-selectin) by 16% (p <0.0001). Even greater reductions of soluble CAMs (sCAMs) were observed in diabetic patients: sICAM-1 was reduced by 27% in the 6 patients with type 2 diabetes (vs. 3% in the patients without diabetes), and sE-selectin was reduced by 32% in the diabetic patients (vs 12% in patients without diabetes). 

Reference:
Abe Y, El-Masri B, Kimball KT, Pownall H, Reilly CF, Osmundsen K, Smith CW, Ballantyne CM. Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion. Arterioscler Thromb Vasc Biol 1998;18:723-731.
Web site